Author Reply: When to take arms against a sea of troubles: CRT- still a challenging question

Dear Editor, The implantation of the biventricular device represents an initial expense and must be weighed against measures of short- and long-term efficacy with regards to survival, morbidity and quality of life (1). In the Editorial published on the Anatolian Journal of Cardiology and entitled “Evaluating patients for CRT, what’s relevant: identifying responders or estimating the amount of potential response”(2) the author declares that identifying the most appropriate candidate for CRT “is also very expensive, requires the appropriate team for selection, implantation and intensive follow- up and a substantial amount of individual patients show little improvement”.